Grant: Operating Grant
Unity Health Toronto
$293,728.00
Transfusion Requirements in Cardaic Surgery II (TRICSII)
EF 2010-11
Résumé
A high proportion of patients having cardiac surgery receive red blood cell transfusions. Yet, we are not certain of when to transfuse these patients as there have not been any randomized controlled trials of red cell transfusions that can be used to guide transfusion practice. There is a risk associated with transfusing patients because of transfusion reactions and there is a risk of morbidity if a transfusion is needed and is not administered. It is thus essential to determine when to transfuse red cells to thes patients. However, as any definitive trial will require thousands of patients, and as there is variability in transfusion practices, pilot studies need to be conducted to ensure adherence to proposed transfusion strategies. We will conduct a multicentred randomised controlled pilot study of two red blood cell transfusion strategies in 200 cardiac surgery patients who are at high risk of receiving a red cell transfusion. The primary outcome is to determine adherence to transfusion strategies. The results of this study will be used to design a large definitive multicentered trial of these transfusion strategies.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
212289
Name
Shehata Nadine
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - C: Digestive, Endocrine and Excretory Systems
Projecttitle
Transfusion Requirements in Cardaic Surgery II (TRICSII)
Programtype2
Operating Grants
Orgnameinp2
Unity Health Toronto
Cihramount2
$293,728
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cardiac Surgery; Randomized Controlled Trial; Red Cell Transfusion
Abstract
A high proportion of patients having cardiac surgery receive red blood cell transfusions. Yet, we are not certain of when to transfuse these patients as there have not been any randomized controlled trials of red cell transfusions that can be used to guide transfusion practice. There is a risk associated with transfusing patients because of transfusion reactions and there is a risk of morbidity if a transfusion is needed and is not administered. It is thus essential to determine when to transfuse red cells to thes patients. However, as any definitive trial will require thousands of patients, and as there is variability in transfusion practices, pilot studies need to be conducted to ensure adherence to proposed transfusion strategies. We will conduct a multicentred randomised controlled pilot study of two red blood cell transfusion strategies in 200 cardiac surgery patients who are at high risk of receiving a red cell transfusion. The primary outcome is to determine adherence to transfusion strategies. The results of this study will be used to design a large definitive multicentered trial of these transfusion strategies.
Competitiondate
201009
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shehata, Nadine; Mazer, David
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $293,728~ $0~